Citations

Institution: Mayo Clinic Clear

Showing 10 of 108119 citations.

Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
Adler, Gail K. , Stowasser, Michael , Correa, Ricardo , Khan, Nadia , Mulatero, Paolo , Murad, M. Hassan , Vaidya, Anand , Young, William F., Zennaro, Maria‐Christina , Corrigan, Maureen D. , Kline, Gregory , Mulatero, Paolo , Murad, M Hassan , Vaidya, Anand , Yang, Jun , Stowasser, Michael , McGowan, Michael , Touyz, Rhian M. , Williams, Tracy Ann , Yang, Jun , Brito, Juan P.

The Journal of Clinical Endocrinology & Metabolism | May 13, 2025 | Volume: 110 | Issue: 9 | Pages: 2453-2495

10.1210/clinem/dgaf284 | PMID 40658480 Get It

Abstract Background Primary aldosteronism (PA), a primary adrenal disorder leading to excessive aldosterone production by one or both adrenal glands, is a common cause of hypertension. It is associated with an increased risk of cardiovascular complications compared with primary hypertension. Despite effective methods for diagnosing and treating PA, it remains markedly underdiagnosed and undertreated. Objective To develop an updated guideline that provides a practical, clinical approach to identifying and managing PA to improve diagnosis rates and encourage targeted treatment. Methods The Guideline Development Panel (GDP), composed of a multidisciplinary panel of clinical experts and experts in systemic review methodology, used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach to define 10 questions related to the diagnosis and treatment of PA. Systematic reviews were conducted for each question. The GDP used the GRADE Evidence to Decision (EtD) framework to consider contextual factors, such as stakeholder values and preferences, costs and required resources, cost-effectiveness, acceptability, feasibility, and the potential impact on health equity. Results We suggest that all individuals with hypertension be screened for PA by measuring aldosterone and renin and determining the aldosterone to renin ratio, and that subsequent clinical care be guided by the results. We suggest that individuals with PA receive PA-specific therapy, either medical or surgical. In individuals who screen positive for PA, we suggest (1) commencement of PA-specific medical therapy in individuals who do not desire or are not candidates for surgery and in situations where the probability of lateralizing PA (excess aldosterone produced by one adrenal) is low based on screening results; and (2) aldosterone suppression testing in situations when screening results indicate an intermediate probability for lateralizing PA and individualized decision making confirms a desire to pursue eligibility for surgical therapy. In those who test positive by aldosterone suppression testing, and in those in whom screening results show a high probability of lateralizing PA (obviating the need for aldosterone suppression testing), we suggest adrenal lateralization with computed tomography scanning and adrenal venous sampling prior to deciding the treatment approach (medical vs surgical). In all individuals with PA and an adrenal adenoma, we suggest performing a 1-mg overnight dexamethasone suppression test. We suggest the use of mineralocorticoid receptor antagonists (MRAs) over epithelial sodium-channel (ENaC) inhibitors in the medical treatment of PA. We suggest the use of spironolactone over other MRAs, given its lower cost and greater availability; however, all MRAs, when titrated to equivalent potencies, are anticipated to have similar efficacy in treating PA. Thus, MRAs with greater mineralocorticoid receptor specificity and fewer androgen/progesterone receptor-mediated side effects may be preferred in some situations. In individuals receiving MRA therapy, we suggest monitoring renin and, in those whose hypertension remains uncontrolled and renin is suppressed, titrating the MRA to increase renin. Conclusion These recommendations provide a practical framework for the diagnosis and treatment of PA. They are based on currently available literature and take into consideration outcomes that are important to key stakeholders. The goal is to increase identification of individuals with PA and, by initiating PA-specific medical or surgical therapy, improve blood pressure control and reduce PA-associated adverse cardiovascular events. The guidelines also highlight important knowledge gaps in PA diagnosis and management.
Core GRADE 4: rating certainty of evidence—risk of bias, publication bias, and reasons for rating up certainty
Guyatt, Gordon , Eachempati, Prashanti, Hultcrantz, Monica , Chu, Derek K. , Flórez, Iván D. , Agoritsas, Thomas , Yao, Liang , Vandvik, Per Olav , Brignardello‐Petersen, Romina , Guyatt, Gordon , Chu, Derek K , Wang, Ying , Eachempati, Prashanti , Iorio, Alfonso , Murad, M. Hassan , Hemkens, Lars G. , Montori, Víctor M.

BMJ | May 13, 2025 | Volume: 389 | Issue: No issue available | Pages: e083864

10.1136/bmj-2024-083864 | PMID 40360206 Get It

Antibiotic-Resistant Nontuberculosis Mycobacteria Infection after Liposuction and Fat Grafting and Full Thickness Cervical Burns after Renuvion Skin Tightening
Riley, Colton, TerKonda, Sarvam P. , Ho, Olivia A. , Riley, Colton

Aesthetic Surgery Journal Open Forum | May 13, 2025 | Volume: 7 | Issue: Supplement_1 | Pages: No page available

10.1093/asjof/ojaf018.015 Get It

Abstract Goals/Purpose To address the complex problems arising from contemporary aesthetic procedures, specifically focusing on the occurrence of antibiotic-resistant non-tuberculosis mycobacterium (NTM) infections following autologous fat grafting and the development of full-thickness burns due to the use of Renuvion for skin tightening. The study underscores the critical need for stringent aseptic techniques, updated sterilization practices, and thorough understanding of new cosmetic technologies to prevent severe complications. Methods/Technique A 45-year-old otherwise healthy female underwent autologous fat grafting to the face and neck tightening with Renuvion in 2023 at an outside aesthetic clinic to address premature facial and cervical ageing. Post-operatively, her course was complicated by multiple midface abscesses from fat grafting and third-degree burns to the neck from Renuvion. She initially sought treatment at a local community hospital, where aspiration was performed which revealed a Mycobacterium fortuitum infection. Despite debridement and antibiotics for the abscesses and xenograft application for her cervical burns, her symptoms persisted, prompting presentation to our tertiary care center. On arrival to our facility, the patient exhibited multiple dermal and subcutaneous abscesses in the premaxillary soft tissues. Broad-spectrum antibiotics were initiated, and she underwent surgical incision and drainage. Cultures identified a multiple resistant Mycobacterium fortuitum complex. Following infectious disease consultation, she commenced a 10-month course of IV antibiotic therapy involving three drugs. Despite this, in 2024, she experienced on-going facial drainage, necessitating further debridement and antibiotic therapy. Results/Complications The patient’s condition was complicated by the discovery of a multiply resistant Mycobacterium fortuitum complex. The infection's resistance to standard antibiotics required an extended and rigorous 10-month treatment regimen involving a combination of macrolide, aminoglycoside, and other antibiotics as well as surgical debridement. Despite aggressive treatment, persistent facial drainage necessitated further surgical intervention. The chronic and recurring nature of the infection significantly increased morbidity and highlighted the need for a multidisciplinary approach to optimize patient outcomes. Additionally, the use of Renuvion led to full-thickness burns, a complication not previously reported in the literature per extensive review. Conclusion This case report and literature review highlights the increasing complexities and potential complications associated with modern aesthetic procedures, specifically antibiotic resistant NTM infections following autologous fat grafting and full thickness burns in the setting of liposuction and Renuvion skin tightening. It underscores the necessity for meticulous aseptic technique, thorough knowledge of equipment, and adherence to modern sterilization protocols to mitigate the risk of infection. Additionally, the development of thermal injuries with Renuvion emphasizes the need for increased reporting to enable proper training and caution with its application. This case report is limited by the inability to definitively identify the source or etiology of the mycobacterium infection and the specific method that led to the full thickness burn, which highlights the need for further investigation and reporting in these areas. This case report is intended to stimulate discussion, investing, and reporting to ultimately improve safety standards in cosmetic surgery and stresses the importance for patients to seek out board-certified and qualified plastic surgeons, as their expertise and adherence to the highest safety standards can significantly reduce the risk of complications such as these.
The Shifting Tides of Sentiment: A 5-Year Analysis of Gender Affirming Surgery Discourse on Social Media
Holan, Cole , Fijany, Arman , Martinez‐Jorge, Jorys

Aesthetic Surgery Journal Open Forum | May 13, 2025 | Volume: 7 | Issue: Supplement_1 | Pages: No page available

10.1093/asjof/ojaf018.008 Get It

Abstract Goals/Purpose This study aims to examine the sentiment and polarization of social media content regarding transgender care. We seek to quantitatively analyze social media posts related to transgender care using sentiment analysis, assessing the extent of positive or negative bias in online discussions about transgender healthcare. By establishing a baseline understanding of how online misinformation may impact public perceptions of transgender care, we highlight the importance of addressing online extremism in healthcare as a public health concern. This research represents the first large-scale natural language processing (NLP) analysis of online sentiment towards transgender care, utilizing sentiment analysis to minimize bias and provide quantitative insights into the impact of online rhetoric on public perception and patient care. Methods/Technique The lead author mined X for posts that mentioned transgender surgery (TG) and gender affirming surgery (GAS) from January 2018 to December 2023. Two different NLP models then analyzed the posts. The first was a binary model that characterized each post as positive or negative. The latter was an emotion-based model that scored each post about seven emotions – fear, sadness, anger, disgust, neutral, surprise, and joy. Posts were then classified by their highest-scoring emotion. An exponential regression analysis within the Python language was performed to study the trend in annual X post volume related to gender surgery. To determine whether there were statistically significant differences in sentiment between transgender (TG) and gender-affirming surgery (GAS) topics, independent two-sample t-tests were conducted for both positive and negative sentiments for each year within the study period. Results/Complications In total, there were 81,264 posts related to gender surgery included in our analysis. In 2018 there were 2,093 posts, compared to 2023 where there were 40,258 posts – a roughly 20-fold increase in annual post volume. In our exponential regression model, annual post volume demonstrated a strong positive trend R2 = 0.939, p = 0.001, Figure 1). Most of the posts were classified as ‘negative’ (63,192 posts, 78%). Mean scores for both GAS and TG posts trended towards more negative and less positive sentiments over the study period (Figure 2). When comparing annual TG to GAS posts, those that mentioned TG were significantly more negative and less positive in every year studied (p < 0.05). Conclusion Our analysis of social media posts related to gender-affirming surgery (GAS) and transgender (TG) care reveals a significant increase in online discourse over the past five years. The volume of posts grew exponentially from 2,093 in 2018 to 40,258 in 2023, representing a 20-fold increase. This rise in online discussion reflects the growing public interest and controversy surrounding transgender healthcare.The sentiment analysis revealed a trend toward increasingly negative rhetoric. A substantial majority (78%) of the posts were classified as negative, indicating a prevalence of critical or hostile attitudes towards GAS and TG care on social media platforms. The mean sentiment scores for both GAS and TG-related posts showed a consistent shift toward more negative and less positive sentiments over time. Notably, posts specifically mentioning transgender individuals or issues consistently displayed more negative and less positive sentiments compared to general GAS-related posts across all years studied. This finding suggests that transgender-specific topics are subject to particularly intense scrutiny and criticism online.These results highlight the urgent need for strategies to address misinformation and negative rhetoric surrounding transgender healthcare on social media platforms. The increasing volume and negativity of online discussions may contribute to a hostile environment for transgender individuals seeking care and for healthcare providers offering these services. Future research should focus on developing effective interventions to counter this trend and promote more balanced, informed discussions of transgender healthcare issues online.
Prevalence, Diagnosis, and Treatment of Cardiac Tumors: A Narrative Review
Rahouma, Mohamed , Mohsen, Hosny , Morsi, Mahmoud , Khairallah, Sherif , Azab, Lilian, Abdelhemid, Maya, Ahmed, Magdy M. El‐Sayed , El-Sayed Ahmed, Magdy M , Kumar, Akshay , Rahouma, Mohammed

Journal of Clinical Medicine | May 13, 2025 | Volume: 14 | Issue: 10 | Pages: 3392

10.3390/jcm14103392 | PMID 40429390 Get It

Cardiac tumors, though rare, present significant diagnostic and therapeutic challenges due to their heterogeneous nature and anatomical complexity. This narrative review synthesizes current evidence on prevalence, diagnostic modalities, and management strategies for primary and metastatic cardiac tumors. Echocardiography, cardiac MRI, and CT remain cornerstone imaging tools for differentiating tumors from non-neoplastic masses, while advances in PET/CT and tissue characterization techniques refine staging and treatment planning. Surgical resection with clear margins (R0) is critical for resectable tumors, particularly benign myxomas, though malignant tumors like sarcomas require multimodal approaches combining surgery, radiotherapy, and systemic therapies. Emerging strategies such as heart autotransplantation and staged resections offer promise for complex cases, while oligometastatic disease management highlights the role of stereotactic radiotherapy and immunotherapy. Key challenges include standardizing resection margins, optimizing neoadjuvant therapies, and addressing high recurrence rates in malignancies. Future directions emphasize integrating AI-driven imaging analysis, molecular biomarkers, and genomic profiling to personalize therapies, alongside global registries to enhance data on rare tumors. Equitable access to advanced diagnostics and multidisciplinary collaboration are essential to improve outcomes. This review underscores the need for standardized guidelines, technological innovation, and patient-centered research to address gaps in cardiac oncology.
Deep Learning-Derived Cardiac Chamber Volumes and Mass From PET/CT Attenuation Scans: Associations With Myocardial Flow Reserve and Heart Failure
Hijazi, Waseem , Shanbhag, Aakash , Miller, Robert J.H. , Kavanagh, Paul , Killekar, Aditya , Lemley, Mark , Wopperer, Samuel, Knight, Stacey , Le, Viet T. , Mason, Steve, Rosamond, T. Thomas, Dey, Damini , Berman, Daniel S. , Carli, Marcelo F. Di , Acampa, Wanda , Dey, Damini , Berman, Daniel , Chareonthaitawee, Panithaya , Di Carli, Marcelo F , Slomka, Piotr J , Miller, Robert J H , Lemley, Mark , Shanbhag, Aakash , Knight, Stacey , Le, Viet T , Mason, Steve, Chareonthaitawee, Panithaya

Circulation: Cardiovascular Imaging | May 13, 2025 | Volume: 18 | Issue: 7 | Pages: No page available

10.1161/circimaging.124.018188 | PMID 40357553 Get It

BACKGROUND: Computed tomography (CT) attenuation correction scans are an intrinsic part of positron emission tomography (PET) myocardial perfusion imaging using PET/CT, but anatomic information is rarely derived from these ultralow-dose CT scans. We aimed to assess the association between deep learning-derived cardiac chamber volumes (right atrial, right ventricular, left ventricular, and left atrial) and mass (left ventricular) from these scans with myocardial flow reserve and heart failure hospitalization. METHODS: We included 18 079 patients with cardiac PET/CT from 6 sites. A deep learning model estimated cardiac chamber volumes and left ventricular mass from CT attenuation correction imaging. Associations between deep learning-derived CT mass and volumes with heart failure hospitalization and reduced myocardial flow reserve were assessed in a multivariable analysis. RESULTS: During a median follow-up of 4.3 years, 1721 (9.5%) patients experienced heart failure hospitalization. Patients with 3 or 4 abnormal chamber volumes were 7× more likely to be hospitalized for heart failure compared with patients with normal volumes. In adjusted analyses, left atrial volume (hazard ratio [HR], 1.25 [95% CI, 1.19–1.30]), right atrial volume (HR, 1.29 [95% CI, 1.23–1.35]), right ventricular volume (HR, 1.25 [95% CI, 1.20–1.31]), left ventricular volume (HR, 1.27 [95% CI, 1.23–1.35]), and left ventricular mass (HR, 1.25 [95% CI, 1.18–1.32]) were independently associated with heart failure hospitalization. In multivariable analyses, left atrial volume (odds ratio, 1.14 [95% CI, 1.0–1.19]) and ventricular mass (odds ratio, 1.12 [95% CI, 1.6–1.17]) were independent predictors of reduced myocardial flow reserve. CONCLUSIONS: Deep learning–derived chamber volumes and left ventricular mass from CT attenuation correction were predictive of heart failure hospitalization and reduced myocardial flow reserve in patients undergoing cardiac PET perfusion imaging. This anatomic data can be routinely reported along with other PET/CT parameters to improve risk prediction.
Trends in Gastric Cancer Mortality in the US: A Population-Based Analysis, 1999-2023
Khan, Saba , Shahid, Hafsa , Fatima, Noor , Khawar, Muneeb , Waqas, Muhammad , Rehan, Aimen, Saif, Maha , Qadeer, Abdul , Iqbal, Javed

No container title available | May 13, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-6327806/v1 Get It

Abstract Purpose Gastric cancer is a leading cause of mortality worldwide, with pronounced variations in outcomes across populations. This study investigates U.S. trends in age-adjusted mortality rates (AAMRs) for gastric cancer from 1999 to 2023, examining differences by sex, race, region, and urbanization to uncover critical patterns and inequities. Methods Data were extracted from the CDC WONDER database using ICD-10 code C16 to identify gastric cancer-related deaths in adults aged 25 and older. AAMRs per 1,000,000 population were calculated and stratified by year, sex, race/ethnicity, geographic region, and urban-rural classification. Trends were analyzed using Joinpoint regression to determine annual percentage changes (APC) and 95% confidence intervals (CI). Statistical significance was set at p < 0.05. Results From 1999 to 2023, there were 312,300 gastric cancer deaths (185,391 men, 126,909 women). Overall, AAMRs declined consistently, with APCs of -3.4 for the period 1999 to 2007, -2.2 for 2007 to 2018, and − 1.2 for 2018 to 2023. Men showed a more pronounced decline, with APCs of -3.6 for 1999 to 2009 and − 2.2 for 2009 to 2023, compared to women, who had APCs of -3.1 for 1999 to 2008, -1.9 for 2008 to 2018, and − 0.8 for 2018 to 2023. Non-Hispanic Black populations experienced a decline in AAMR with an APC of -3.3 for 1999 to 2020, while Hispanic/Latino and Asian/Pacific Islander populations showed declines with APCs of -2.8 for 1999 to 2011 and − 3.8 for 1999 to 2020, respectively. Metropolitan areas saw AAMR reductions with APCs of -3.3 for 1999 to 2008 and − 2.2 for 2008 to 2020, while non-metropolitan areas had larger initial declines with an APC of -3.6 for 1999 to 2006 but slower decreases with an APC of -2.0 for 2006 to 2020. Geographically, the Northeast had the highest AAMR (62.9), followed by the West (61.7), South (57.4), and Midwest (50.9). Hawaii recorded the highest state-level AAMR (96.5), while Wyoming had the lowest (36.6). States in the top 90th percentile included Alaska, California, and New York, whereas Utah, Idaho, and Iowa were among the lowest. Conclusion Gastric cancer mortality in the U.S. has declined over the past two decades, but the pace of reduction has slowed in recent years. Significant disparities persist across sex, racial, and geographic groups, underscoring the need for targeted interventions to address these inequities and improve outcomes in vulnerable populations.
BMDD: A Probabilistic Framework for Accurate Imputation of Zero-inflated Microbiome Sequencing Data
Zhou, Huijuan , Chen, Jun , Zhang, Xianyang , Chen, Jun , Zhou, Huijuan

No container title available | May 13, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1101/2025.05.08.652808 | PMID 40462952 Get It

Abstract Microbiome sequencing data are inherently sparse and compositional, with excessive zeros arising from biological absence or insufficient sampling. These zeros pose significant challenges for downstream analyses, particularly those that require log-transformation. We introduce BMDD (BiModal Dirichlet Distribution), a novel probabilistic modeling framework for accurate imputation of microbiome sequencing data. Unlike existing imputation approaches that assume unimodal abundance, BMDD captures the bimodal abundance distribution of the taxa via a mixture of Dirichlet priors. It uses variational inference and a scalable expectation-maximization algorithm for efficient imputation. Through simulations and real microbiome datasets, we demonstrate that BMDD outperforms competing methods in reconstructing true abundances and improves the performance of differential abundance analysis. Through multiple posterior samples, BMDD enables robust inference by accounting for uncertainty in zero imputation. Our method offers a principled and computationally efficient solution for analyzing high-dimensional, zero-inflated microbiome sequencing data and is broadly applicable in microbial biomarker discovery and host-microbiome interaction studies. BMDD is available at: https://github.com/zhouhj1994/BMDD . Author Summary Understanding the microbes living in and on our bodies—the microbiome—relies on analyzing complex sequencing data. However, these data often contain many zeros, either because a microbe is truly absent or simply missed due to insufficient sampling. These missing values make it hard to accurately analyze microbial patterns and identify important differences between groups, especially for methods that work on a log scale. To address this, we developed a new method called BMDD that uses a more realistic model to impute the zeros. Unlike existing tools that assume each microbe follows an unimodal abundance distribution, BMDD allows for microbes to follow a bimodal distribution, so they could behave differently in different conditions. It provides not just a single guess, but a range of possible values to better reflect the uncertainty. Our testing shows that BMDD more accurately recovers the true microbial profiles and improves the ability to detect meaningful differences between groups. This method can help researchers gain clearer insights into how the microbiome affects health and disease.
Navigating the impact of the 21st‐Century Cures Act Final Rule: A national cross‐sectional survey of US genetic counselors
Lowe, Chenery , Duncan, Laura , Morris, Victoria , Anderson, Katherine , Dratch, Laynie , Mathews, Debra , Mathews, Debra J H , Anderson, Katherine C , Duncan, Laura , Morris, Victoria

Journal of Genetic Counseling | May 13, 2025 | Volume: 34 | Issue: 3 | Pages: No page available

10.1002/jgc4.70005 | PMID 40356043 Get It

Abstract The 21st Century Cures Act Final Rule (Final Rule) increases patient access to their health records but raises concerns about distress and misunderstanding of automatically released results and documentation. Little is known about genetic counselors' (GCs') experiences with the Final Rule. In Fall 2023, we conducted a cross‐sectional survey of US GCs about the Final Rule's perceived impact on practice and assessed if being the ordering versus non‐ordering provider for genetic testing affected perceptions of Final Rule‐related changes. GCs ( n = 102) reported demographic and workplace characteristics, institutional policy changes, workflow changes, and perceived patient harms and benefits due to the Final Rule. To compare ordering and non‐ordering providers, we conducted Fisher's exact tests for categorical variables and trend tests for ordinal variables. Open‐response questions elicited examples of positive and negative patient impacts, the effects of patient characteristics, and practice changes in response to the Final Rule. Twenty‐seven GCs were ordering providers and 66 were non‐ordering providers. Relative to ordering providers, non‐ordering providers expressed stronger agreement with statements indicating concern about the emotional impact on patients reviewing results or notes without support ( p = 0.002, 33% vs. 51% strongly agree), patients misunderstanding or misinterpreting results ( p = 0.025, 44% vs. 70% strongly agree), and patients contacting the inappropriate party to discuss results ( p = 0.023, 19% vs. 48% strongly agree). Agreement with the statement “patients have more knowledge/context/questions at our disclosure session due to previous results review” also differed by ordering provider status ( p = 0.007). In open responses, GCs expressed concerns about patients' strong emotional reactions, patients misinterpreting results, workflow disruptions, and widening health disparities. Benefits included patients' ability to be reassured, informed, or empowered earlier; ease of sharing health information; more efficient workflow due to the automatic release of results. These results emphasize the importance of clear communication within health systems and between patients and providers.
Relationship between use of anti‐platelet agents, oral anti‐coagulants, and Aβ burden with cerebral microhemorrhages in cognitively asymptomatic adults
Gay, Marcus , Baldaranov, Dobri , Jack, Clifford R. , Aisen, Paul, Jack, Clifford R , Donohue, Michael , Sperling, Reisa Anne , Rafii, Michael S.

Alzheimer's & Dementia | May 13, 2025 | Volume: 21 | Issue: 5 | Pages: No page available

10.1002/alz.70167 | PMID 40356042 Get It

AbstractINTRODUCTIONCerebral microhemorrhages (CMHs) are detectable by magnetic resonance imaging (MRI). CMHs in deep brain regions are linked to hypertensive vasculopathy, while those in lobar regions with amyloid beta (Aβ) deposition in blood vessels. This study aims to determine the association between anti‐thrombotic treatment and CMH prevalence among cognitively asymptomatic adults, and to assess the role of Aβ markers, apolipoprotein E (APOE) ε4 carrier status, and cardiovascular risk factors in CMH development.METHODSUsing baseline data from the Anti‐Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) and Longitudinal Evaluation of Amyloid Risk and Neurodegeneration (LEARN) studies, we examined CMH presence via 3T MRI, along with medication use, APOE ε4 carrier status, medical history, and blood pressure.RESULTSOur analysis showed a significantly higher prevalence of CMHs in the A4 cohort (17.3%) compared to the LEARN cohort (2.6%).DISCUSSIONFactors such as male sex, age, Aβ markers, and APOE ε4 status were significantly associated with higher CMH prevalence in the A4 cohort. However, anti‐thrombotic treatment did not show association with overall CMHs.Highlights Male sex, age > 75, amyloid beta (Aβ) burden, and apolipoprotein E (APOE) ε4 homozygosity are significantly associated with higher prevalence of CMHs (cerebral microhemorrhages) in a cohort of cognitively asymptomatic individuals. Male sex, age > 75, Aβ burden, and APOE ε4 homozygosity are significantly associated with higher prevalence of lobar CMHs in a cohort of cognitively asymptomatic individuals. Anti‐platelet or anti‐coagulant usage were not associated with an increased prevalence of CMHs in either brain location or overall, in a cohort of cognitively asymptomatic individuals. History of a lipid disorder is associated with a higher prevalence of lobar CMHs in a cohort of cognitively asymptomatic individuals.